Seth Klarman
Baupost Group
Seth Klarman FORWARD PHARMA A/S-ADR stake
total: 272
Baupost Group FWPAY trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2014 Q4
- Held for:
- 14 quarters
- Latest activity:
- 2018 Q2
According to 2026 Q2 report, Seth Klarman doesn't hold any FORWARD PHARMA A/S-ADR (FWPAY) shares. To date, the estimated cost basis is nearly $41128.11 for "buy" trades and estimated average "sell" price is $5406.72. Baupost Group first purchased FWPAY in 2014 Q4, initially acquiring 2,684 shares. Since the initial investment in FORWARD PHARMA A/S-ADR (FWPAY), Baupost Group has made 6 more transactions.
When did Seth Klarman sell FORWARD PHARMA A/S-ADR (FWPAY)?
Seth Klarman sold off the entire FORWARD PHARMA A/S-ADR (FWPAY) position in 2018 Q2.
When did Seth Klarman buy FORWARD PHARMA A/S-ADR (FWPAY)?
Seth Klarman first invested in FORWARD PHARMA A/S-ADR (FWPAY) in 2014 Q4 at the reported quarter-end price of $41,659.43 per share.
What's the cost basis of Baupost Group's FWPAY stake?
The estimated cost basis for FORWARD PHARMA A/S-ADR (FWPAY) stake is around $41,128.11 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $41,128.11
- Weighted AVG sell price:
- $5,406.72
Seth Klarman's historical trades in FORWARD PHARMA A/S-ADR
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q2
|
0.00%
|
$4,339.83
|
-100% (-1,424.02)
|
|||
|
2018 Q1
|
0.06%
|
$4,339.83
|
-31.87% (-665.98)
|
|||
|
2017 Q4
|
0.15%
|
$7,359.81
|
-35.33% (-1,141.68)
|
|||
|
2017 Q3
|
0.49%
|
$12,139.82
|
+1.56% (+49.6)
|
|||
|
2017 Q2
|
1.48%
|
$40,659.25
|
+14.15% (+394.33)
|
|||
|
2017 Q1
|
1.41%
|
$43,019.28
|
+3.88% (+104.06)
|
|||
|
2014 Q4
|
2.20%
|
$41,659.43
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.